Three insights:
1. Talomon Capital likely amassed its entire stake in Surgery Partners in recent weeks.
2. Talomon Capital manages about $307 million for clients, meaning its investment in Surgery Partners accounts for about 5 percent of its total investments.
3. The value of Surgery Partners’ shares has dropped two-thirds in the past year. Several top executives have left the company, which is working to close a federal investigation into its drug-testing practices.
More articles on transactions and valuation:
Connecticut hospital weighs investing in surgery center — 5 insights
Physicians Endoscopy names new CEO & more — 9 ASC industry notes
California HCA ASC real estate listed for sale at $7M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
